Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catherine Maari

Showing results (21-30 of 43) with videos related to

Pageof 5
Sort By:
Journal of Cutaneous Medicine and Surgery|July 3, 2013
Therapy of ulcerated hemangiomasCatherine C McCuaig, Lynn Cohen, Julie Powell, et al.
Journal of the American Academy of Dermatology|May 28, 2018
Maintenance of skin clearance with ixekizumab treatment of psoriasis: Three-year results from the UNCOVER-3 studyCraig Leonardi, Catherine Maari, Sandra Philipp, et al.
American Journal of Clinical Dermatology|April 7, 2021
Extended Safety Analysis of Baricitinib 2 mg in Adult Patients with Atopic Dermatitis: An Integrated Analysis from Eight Randomized Clinical TrialsBrett King, Catherine Maari, Edward Lain, et al.
European Journal of Immunology|June 19, 2025
Tissue-Resident Memory and Follicular/Peripheral Helper PD-1<sup>+</sup> T Cells Infiltrate Lesional Skin in Atopic DermatitisHeena Mehta, Léane Pellerin, Manuel Rubio, et al.
Clinical Pharmacology and Therapeutics|April 18, 2020
Response to Inhibition of Receptor-Interacting Protein Kinase 1 (RIPK1) in Active Plaque Psoriasis: A Randomized Placebo-Controlled StudyKathleen Weisel, Scott Berger, Kim Papp, et al.
Dermatologic Therapy|August 21, 2022
Management of moderate-to-severe plaque psoriasis with biologics: A treat-to-target position paperJensen Yeung, Marc Bourcier, Melinda J Gooderham, et al.
The Journal of Investigative Dermatology|March 14, 2017
TNF-α Antagonist and Vascular Inflammation in Patients with Psoriasis Vulgaris: A Randomized Placebo-Controlled StudyRobert Bissonnette, François Harel, James G Krueger, et al.
The Journal of Investigative Dermatology|February 1, 2021
Differential Changes in Inflammatory Mononuclear Phagocyte and T-Cell Profiles within Psoriatic Skin during Treatment with Guselkumab vs. SecukinumabHeena Mehta, Shunya Mashiko, Julianty Angsana, et al.
Journal of Cutaneous Medicine and Surgery|December 15, 2022
Clinical Implications of Targeting the JAK-STAT Pathway in Psoriatic Disease: Emphasis on the TYK2 PathwayWei Jing Loo, Irina Turchin, Vimal H Prajapati, et al.
Journal of Dermatological Science|October 17, 2016
Palmoplantar pustular psoriasis (PPPP) is characterized by activation of the IL-17A pathwayRobert Bissonnette, Judilyn Fuentes-Duculan, Shunya Mashiko, et al.
Pageof 5

Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
Journal of Cutaneous Medicine and Surgery|July 3, 2013
Therapy of ulcerated hemangiomasCatherine C McCuaig, Lynn Cohen, Julie Powell, et al.
Journal of the American Academy of Dermatology|May 28, 2018
Maintenance of skin clearance with ixekizumab treatment of psoriasis: Three-year results from the UNCOVER-3 studyCraig Leonardi, Catherine Maari, Sandra Philipp, et al.
American Journal of Clinical Dermatology|April 7, 2021
Extended Safety Analysis of Baricitinib 2 mg in Adult Patients with Atopic Dermatitis: An Integrated Analysis from Eight Randomized Clinical TrialsBrett King, Catherine Maari, Edward Lain, et al.
European Journal of Immunology|June 19, 2025
Tissue-Resident Memory and Follicular/Peripheral Helper PD-1<sup>+</sup> T Cells Infiltrate Lesional Skin in Atopic DermatitisHeena Mehta, Léane Pellerin, Manuel Rubio, et al.
Clinical Pharmacology and Therapeutics|April 18, 2020
Response to Inhibition of Receptor-Interacting Protein Kinase 1 (RIPK1) in Active Plaque Psoriasis: A Randomized Placebo-Controlled StudyKathleen Weisel, Scott Berger, Kim Papp, et al.
Dermatologic Therapy|August 21, 2022
Management of moderate-to-severe plaque psoriasis with biologics: A treat-to-target position paperJensen Yeung, Marc Bourcier, Melinda J Gooderham, et al.
The Journal of Investigative Dermatology|March 14, 2017
TNF-α Antagonist and Vascular Inflammation in Patients with Psoriasis Vulgaris: A Randomized Placebo-Controlled StudyRobert Bissonnette, François Harel, James G Krueger, et al.
The Journal of Investigative Dermatology|February 1, 2021
Differential Changes in Inflammatory Mononuclear Phagocyte and T-Cell Profiles within Psoriatic Skin during Treatment with Guselkumab vs. SecukinumabHeena Mehta, Shunya Mashiko, Julianty Angsana, et al.
Journal of Cutaneous Medicine and Surgery|December 15, 2022
Clinical Implications of Targeting the JAK-STAT Pathway in Psoriatic Disease: Emphasis on the TYK2 PathwayWei Jing Loo, Irina Turchin, Vimal H Prajapati, et al.
Journal of Dermatological Science|October 17, 2016
Palmoplantar pustular psoriasis (PPPP) is characterized by activation of the IL-17A pathwayRobert Bissonnette, Judilyn Fuentes-Duculan, Shunya Mashiko, et al.
Pageof 5